Replay (Drug Discovery) Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
1
Replay (Drug Discovery) General Information
Description
Developer of a genome writing platform designed to reprogram biology for genomic medicine. The company offers gene therapy that utilizes viruses to deliver genetic material into cells, aiming to treat or prevent diseases at the genetic level, enabling healthcare professionals to deliver big genes to treat rare genetic diseases.
Contact Information
Website
www.replay.bioCorporate Office
- 5555 Oberlin Drive
- Suite 120
- San Diego, CA 92121
- United States
Corporate Office
- 5555 Oberlin Drive
- Suite 120
- San Diego, CA 92121
- United States
Replay (Drug Discovery) Timeline
Replay (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Replay (Drug Discovery) Comparisons
Industry
Financing
Details
Replay (Drug Discovery) Competitors (2)
One of Replay (Drug Discovery)’s 2 competitors is Intellia Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Tessera Therapeutics | Venture Capital-Backed | Cambridge, MA |
Replay (Drug Discovery) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Replay (Drug Discovery) Patents
Replay (Drug Discovery) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240124551-A1 | Methods and compositions for cellular therapy | Pending | 20-Oct-2020 |
Replay (Drug Discovery) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Replay (Drug Discovery) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Replay (Drug Discovery) Investments (1)
Replay (Drug Discovery)’s most recent deal was a Joint Venture with Syena. The deal was made on 10-Feb-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Syena | 10-Feb-2023 | Joint Venture | Biotechnology |
Replay (Drug Discovery) FAQs
-
When was Replay (Drug Discovery) founded?
Replay (Drug Discovery) was founded in 2020.
-
Where is Replay (Drug Discovery) headquartered?
Replay (Drug Discovery) is headquartered in San Diego, CA.
-
What is the size of Replay (Drug Discovery)?
Replay (Drug Discovery) has 32 total employees.
-
What industry is Replay (Drug Discovery) in?
Replay (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Replay (Drug Discovery) a private or public company?
Replay (Drug Discovery) is a Private company.
-
What is Replay (Drug Discovery)’s current revenue?
The current revenue for Replay (Drug Discovery) is .
-
How much funding has Replay (Drug Discovery) raised over time?
Replay (Drug Discovery) has raised $83.4M.
-
Who are Replay (Drug Discovery)’s investors?
Alpen Capital (Investor), Calm Ventures, CureDuchenne Ventures, , and SGInnovate are 5 of 15 investors who have invested in Replay (Drug Discovery).
-
Who are Replay (Drug Discovery)’s competitors?
Intellia Therapeutics and Tessera Therapeutics are competitors of Replay (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
